Protonix


  • Feb
    16
    By Reuters

    Wyeth Pharmaceuticals Inc is seeking $960 million in damages from Sun Pharmaceutical Industries for alleged patent infringement in launching a generic version of acid reflux drug Protonix in the United

  • Mar
    09
    By Kumar Shankar Roy

    BSE-listed Sun Pharmaceutical Industries got a reprieve from a US court as Pfizer-controlled Wyeth’s complaint on Protonix, an anti-ulcer drug, was thrown out.
    The US district court for the eastern